ABC of mens health

February 5, 2009

Swimming can cut men’s risk of dying in half

Filed under: Uncategorized — Tags: — poster @ 1:35 pm

A new study shows that swimming cuts men’s risk of dying by about 50% compared to runners, walkers and sedentary peers.
The University of South Carolina study led by Dr. Steven Blair evaluated comprehensive physical exams and behavioral surveys from thousands of people who were enrolled in the Aerobics Center Longitudinal Study (ACLS) over the last 32 years. The results were presented (more…)

January 8, 2009

Obesity May Play A Role In Erectile Dysfunction

Filed under: Uncategorized — Tags: , , , — poster @ 7:35 pm

A new study may be an important motivational tool for obese men to lose weight! According to a study published in The Journal of Sexual Medicine, the official journal of the International Society for Sexual Medicine, obese men with erectile dysfunction (ED) are shown to have low levels of hormones, such as testosterone. A correlation between certain conditions associated with obesity, particularly hypertension, (more…)

December 3, 2008

Link Found Between Obesity And Erectile Dysfunction

Filed under: Uncategorized — Tags: , , , — poster @ 10:35 pm

A new study states that obese men with erectile dysfunction (ED) are shown to have low levels of hormones, such as testosterone. The findings also show that certain conditions associated with obesity, particularly hypertension, are the most important determinants of obesity-related ED. The study was published in (more…)

November 28, 2008

CHEST 2008: New Pulmonary Hypertension Research Presented

Filed under: Uncategorized — Tags: , , , — poster @ 5:35 pm

#6363
TADALAFIL PROVES EFFECTIVE THERAPY FOR PULMONARY HYPERTENSION
generishe levitra pillen Ohne Rezept New research shows that the erectile dysfunction drug, tadalafil, may be an effective adjunct therapy for patients with pulmonary arterial hypertension (PAH). Italian researchers randomized (more…)

November 27, 2008

Premature Ejaculation - Plethora Solutions Has Completed European Phase III Trial Of PSD502

Filed under: Uncategorized — Tags: , , , , — poster @ 4:35 pm

Sciele Pharma, Inc. ("Sciele") (NASDAQ:SCRX), a specialty pharmaceutical company, today announced that Plethora Solutions Holdings PLC ("Plethora") (AIM:PLE), the specialist developer of products for the treatment and management of urological disorders, has completed its European Phase III study of PSD502 for the treatment of premature ejaculation (PE) in Europe. The study (more…)

November 22, 2008

Penile Trauma, Peyronie’s Disease And Erectile Dysfunction

Filed under: Uncategorized — Tags: , , , , , — poster @ 10:35 am

Latest News For This Category
Importance Of Penile Prostheses In The Treatment Of ED
19 Sep 2008
Penile Trauma, Peyronie’s Disease And Erectile Dysfunction
19 Sep 2008
Assessment And Treatment Of Erectile Function
19 Sep 2008
View more news…
Latest Videos for Erectile Dysfunction
Penile Pump Expectations
For many men suffering (more…)

Assessment And Treatment Of Erectile Function

Filed under: Uncategorized — Tags: , , — poster @ 10:35 am

Kaufen viagra pillen mastercard BERLIN, GERMANY (UroToday.com) - After reviewing the prevalence of erectile dysfunction (ED), Dr. Matthews emphasized the importance of a detailed history, physical examination and laboratory testing in the man complaining of ED.
In 2006 it was estimated (more…)

July 26, 2008

Study Confirms That Levitra® On Demand Is Effective In Patients With ED After Nerve-sparing Prostatectomy

Filed under: Uncategorized — Tags: , , , , — poster @ 2:35 pm

A study published in the European Urology journal demonstrated that Levitra® (vardenafil, HCI) is highly efficacious in men with erectile dysfunction (ED) even shortly after radical nerve-sparing prostatectomy. This landmark study conducted by (more…)

July 8, 2008

Peyronie’s Disease: Characteristics & Treatments

Filed under: Uncategorized — Tags: , , , — poster @ 10:35 pm

Peyronie’s disease is characterized by a plaque, or hard lump, that develops on the upper or lower side of the penis in layers containing erectile tissue. It starts with an inflammation and can develop into a hardened scar. Symptoms may develop slowly or appear overnight and they consist of reduced flexibility, pain, curved and (more…)

February 14, 2008

Sciele Pharma And Plethora Solutions Announce Final Analysis Of PSD502 For Premature Ejaculation; All Primary And Secondary Endpoints Met In Phase III

Filed under: Uncategorized — Tags: , , , , — poster @ 9:35 pm

Sciele Pharma, Inc., a Shionogi Company, and Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE), the specialist developer of products for the treatment and management of urological disorders, today announced the final analysis of its European Phase III double-blind placebo-controlled study of PSD502 for the treatment of premature ejaculation (’PE’). (more…)

Powered by WordPress